Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Wehling

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Arzneimittel-Forschung|March 25, 2010
Multimorbidity and polypharmacy: which betablocker to use in relation to the pharmacokinetic profile and interaction potentialMartin Wehling
European Journal of Clinical Pharmacology|August 29, 2014
Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effectsMartin Wehling
Arzneimittel-Forschung|March 7, 2002
[Comparison beta-blockers and their relevance to pharmacologic therapy of cardiovascular diseases]Martin Wehling
The Journal of Steroid Biochemistry and Molecular Biology|January 28, 2017
Rapid actions of aldosterone revisited: Receptors in the limelightMartin Wehling
Journal of the American Geriatrics Society|March 13, 2009
Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the agedMartin Wehling
MMW Fortschritte Der Medizin|August 4, 2009
[The underestimated catastrophy (interview by Dr. Jochen Aumiller)]Martin Wehling
Cardiovascular Therapeutics|July 15, 2010
Future of anticoagulant therapyJob Harenberg, Martin Wehling
Nature Reviews. Molecular Cell Biology|January 4, 2003
Nongenomic actions of steroid hormonesRalf Lösel, Martin Wehling
European Geriatric Medicine|June 29, 2021
Correction to: FORTA(Fit-fOR-The-Aged)-based medication optimization: retrospective analysis of experiences from an unconventional outpatient serviceSophia Rieg, Martin Wehling
European Geriatric Medicine|July 9, 2021
Correction to: Knowledge on and use of the FORTA ("Fit fOR The Aged")‑list and the FORTA App by general practitioners in Baden‑Württemberg, GermanyLiesbeth Meyer, Martin Wehling
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Arzneimittel-Forschung|March 25, 2010
Multimorbidity and polypharmacy: which betablocker to use in relation to the pharmacokinetic profile and interaction potentialMartin Wehling
European Journal of Clinical Pharmacology|August 29, 2014
Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effectsMartin Wehling
Arzneimittel-Forschung|March 7, 2002
[Comparison beta-blockers and their relevance to pharmacologic therapy of cardiovascular diseases]Martin Wehling
The Journal of Steroid Biochemistry and Molecular Biology|January 28, 2017
Rapid actions of aldosterone revisited: Receptors in the limelightMartin Wehling
Journal of the American Geriatrics Society|March 13, 2009
Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the agedMartin Wehling
MMW Fortschritte Der Medizin|August 4, 2009
[The underestimated catastrophy (interview by Dr. Jochen Aumiller)]Martin Wehling
Cardiovascular Therapeutics|July 15, 2010
Future of anticoagulant therapyJob Harenberg, Martin Wehling
Nature Reviews. Molecular Cell Biology|January 4, 2003
Nongenomic actions of steroid hormonesRalf Lösel, Martin Wehling
European Geriatric Medicine|June 29, 2021
Correction to: FORTA(Fit-fOR-The-Aged)-based medication optimization: retrospective analysis of experiences from an unconventional outpatient serviceSophia Rieg, Martin Wehling
European Geriatric Medicine|July 9, 2021
Correction to: Knowledge on and use of the FORTA ("Fit fOR The Aged")‑list and the FORTA App by general practitioners in Baden‑Württemberg, GermanyLiesbeth Meyer, Martin Wehling
Pageof 17